Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Experiments suggest that SARS-CoV-2 infections after vaccination trigger antibody levels similar to those in people whose infections preceded their vaccination.
Researchers at WHO technology-transfer hub complete first step in a project aimed at building capacity for vaccine manufacturing in low- and middle-income countries.
US-based research administrator Peter Highnam will lead the newly established agency, which the government says will fund science with minimal bureaucracy.
COVID vaccine boosters are proving a useful tool against Omicron, but scientists say that endless boosting might not be a practical or sustainable strategy.